Transvaginal mesh implants independent review: interim report
This interim report outlines the work of the Independent Review of the use, safety and efficacy of transvaginal mesh implants in the treatment of stress urinary incontinence (SUI) and pelvic organ prolapse (POP).
Footnotes
1. http://www.gov.scot/Publications/2014/06/2806
2. http://www.nice.org.uk/guidance/published?type=ipg
3. http://www.nice.org.uk/guidance/cg171
7. http://www.prisma-statement.org/
8. http://www.cochranelibrary.com/
9. A full list of refernces in Chapter 5 can be found in the Reference section
10. NICE CG 171 (2013). "Urinary incontinence in women: the management of urinary incontinence in women" provides an update to the first edition of the NICE guidance published in 2006. This was informed by the Cody et al systematic review undertaken by the UK HTA included here. The 2013 edition of the NICE guideline added material from RCTs not included in the Cody et al review, as well as drawing on the extant Cochrane Reviews available at that time. As four of these Cochrane Reviews were published in 2013 (and therefore drawing on the same additional RCT material as NICE) or post 2013 (and therefore drawing on material not available to NICE, the decision to remain with the original Systematic Review and the updated Cochrane Reviews was taken.
11. Teo R1, Moran P, Mayne C, Tincello D. Randomized trial of tension-free vaginal tape and tension-free vaginal tape-obturator for urodynamic stress incontinence in women. J Urol. 2011 Apr; 185(4):1350-5. doi: 10.1016/j.juro.2010.11.064.
12. http://www.gov.scot/Resource/0045/00453999.pdf
14. http://www.mhra.gov.uk/home/groups/comms-ic/documents/websiteresources/con205383.pdf
15. An adverse event can be defined as an event that could have caused, or did result in, harm to people or groups of people.
16. 2006 Drug Safety http://www.ncbi.nlm.nih.gov/pubmed/16689555
Contact
Email: Gillian McCallum
There is a problem
Thanks for your feedback